Aztreonam lysine for inhalation

DRUG2 trials

Sponsors

Gilead Sciences, Novartis Pharmaceuticals

Conditions

Cystic FibrosisPseudomonas Aeruginosa Airway Infection

Unknown Phase

Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection

Gilead SciencesCystic Fibrosis, Pseudomonas Aeruginosa Airway Infection

Updated: 2011-08-02

Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis

CompletedNCT01460836

Novartis PharmaceuticalsCystic Fibrosis

Start: 2010-04-30Updated: 2011-10-27